Table 5.
Parasitic density and its clearance of the participants treated with chloroquine plus primaquine
| Types of treatment failure | Pt.ID | Sex | Age (yr) | FUD | Parasitic density | Ratio/µl of para. dens at day of treatment failure to day 0 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| At day 0 (baseline)/µl | At the day of treatment failure/µl | |||||||||
| ETF | 506 | M | 6 | Day 3 | 4080 | 5300 | 1.3 | |||
| LCF | 546 | M | 6 | Day 35 | 8501 | 8000 | 0.9 | |||
| LPF | 517 | M | 4 | Day 42 | 2560 | 580 | 0.2 | |||
| 518 | M | 10 | Day 42 | 2240 | 8960 | 4.0 | ||||
| 528 | M | 21 | Day 14 | 2640 | 6000 | 2.3 | ||||
| 559 | M | 11 | Day 14 | 2600 | 3590 | 1.4 | ||||
| 598 | F | 9 | Day 14 | 780 | 800 | 1.03 | ||||
| FUD | Day0 | Day1 | Day 2 | Day 3 | Day 7 | Day 14 | Day 21 | Day28 | Day 35 | Day 42 |
| Gam carrier (n) | 26 | 9 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Presence of asec para (n) | 100 | 54 | 11 | 6 | 0 | 3 | 0 | 0 | 1 | 2 |